A novel full-human CD22-CAR T cell therapy with potent activity against CD22 B-ALL.
作者信息
Tan Yue, Cai Haodong, Li Chuo, Deng Biping, Song Weiliang, Ling Zhuojun, Hu Guang, Yang Yongkun, Niu Panpan, Meng Guangrong, Cheng Wei, Xu Jinlong, Duan Jiajia, Wang Zelin, Yu Xinjian, Feng Xiaoming, Zhou Jianfeng, Pan Jing
机构信息
State Key Laboratory of Experimental Hematology, Boren Biotherapy Translational Laboratory, Boren Clinical Translational Center, Department of Hematology, Beijing Boren Hospital, Beijing, 100070, China.
State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.
出版信息
Blood Cancer J. 2021 Apr 10;11(4):71. doi: 10.1038/s41408-021-00465-9.
Abstract
摘要
Zotero 插件